Potent, metabolically stable benzopyrimido-pyrrolo-oxazine-dione (BPO) CFTR inhibitors for polycystic kidney disease.

Source:http://linkedlifedata.com/resource/pubmed/id/21707078

J. Med. Chem. 2011 Aug 11 54 15 5468-77

Download in:

View as

Triples

General Info

PMID
21707078